Bile acids contribute to the development of non-alcoholic steatohepatitis in mice

Background & Aims: Through FXR and TGR5 signaling, bile acids (BAs) modulate lipid and glucose metabolism, inflammation and fibrosis. Hence, BAs returning to the liver after enteric secretion, modification and reabsorption may contribute to the pathogenesis of non-alcoholic steatohepatitis (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Justine Gillard, Laure-Alix Clerbaux, Maxime Nachit, Christine Sempoux, Bart Staels, Laure B. Bindels, Anne Tailleux, Isabelle A. Leclercq
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
FXR
Acceso en línea:https://doaj.org/article/d288e103d667458db40d774aae2af880
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d288e103d667458db40d774aae2af880
record_format dspace
spelling oai:doaj.org-article:d288e103d667458db40d774aae2af8802021-11-18T04:51:17ZBile acids contribute to the development of non-alcoholic steatohepatitis in mice2589-555910.1016/j.jhepr.2021.100387https://doaj.org/article/d288e103d667458db40d774aae2af8802022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589555921001634https://doaj.org/toc/2589-5559Background & Aims: Through FXR and TGR5 signaling, bile acids (BAs) modulate lipid and glucose metabolism, inflammation and fibrosis. Hence, BAs returning to the liver after enteric secretion, modification and reabsorption may contribute to the pathogenesis of non-alcoholic steatohepatitis (NASH). Herein, we characterized the enterohepatic profile and signaling of BAs in preclinical models of NASH, and explored the consequences of experimental manipulation of BA composition. Methods: We used high-fat diet (HFD)-fed foz/foz and high-fructose western diet-fed C57BL/6J mice, and compared them to their respective controls. Mice received a diet supplemented with deoxycholic acid (DCA) to modulate BA composition. Results: Compared to controls, mice with NASH had lower concentrations of BAs in their portal blood and bile, while systemic BA concentrations were not significantly altered. Notably, the concentrations of secondary BAs, and especially of DCA, and the ratio of secondary to primary BAs were strikingly lower in bile and portal blood of mice with NASH. Hence, portal blood was poor in FXR and TGR5 ligands, and conferred poor anti-inflammatory protection in mice with NASH. Enhanced primary BAs synthesis and conversion of secondary to primary BAs in NASH livers contributed to the depletion in secondary BAs. Dietary DCA supplementation in HFD-fed foz/foz mice restored the BA concentrations in portal blood, increased TGR5 and FXR signaling, improved the dysmetabolic status, protected from steatosis and hepatocellular ballooning, and reduced macrophage infiltration. Conclusions: BA composition in the enterohepatic cycle, but not in systemic circulation, is profoundly altered in preclinical models of NASH, with specific depletion in secondary BAs. Dietary correction of the BA profile protected from NASH, supporting a role for enterohepatic BAs in the pathogenesis of NASH. Lay summary: This study clearly demonstrates that the alterations of enterohepatic bile acids significantly contribute to the development of non-alcoholic steatohepatitis in relevant preclinical models. Indeed, experimental modulation of bile acid composition restored perturbed FXR and TGR5 signaling and prevented non-alcoholic steatohepatitis and associated metabolic disorders.Justine GillardLaure-Alix ClerbauxMaxime NachitChristine SempouxBart StaelsLaure B. BindelsAnne TailleuxIsabelle A. LeclercqElsevierarticleNAFLDNASHTGR5FXRmetabolic syndromeDiseases of the digestive system. GastroenterologyRC799-869ENJHEP Reports, Vol 4, Iss 1, Pp 100387- (2022)
institution DOAJ
collection DOAJ
language EN
topic NAFLD
NASH
TGR5
FXR
metabolic syndrome
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle NAFLD
NASH
TGR5
FXR
metabolic syndrome
Diseases of the digestive system. Gastroenterology
RC799-869
Justine Gillard
Laure-Alix Clerbaux
Maxime Nachit
Christine Sempoux
Bart Staels
Laure B. Bindels
Anne Tailleux
Isabelle A. Leclercq
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
description Background & Aims: Through FXR and TGR5 signaling, bile acids (BAs) modulate lipid and glucose metabolism, inflammation and fibrosis. Hence, BAs returning to the liver after enteric secretion, modification and reabsorption may contribute to the pathogenesis of non-alcoholic steatohepatitis (NASH). Herein, we characterized the enterohepatic profile and signaling of BAs in preclinical models of NASH, and explored the consequences of experimental manipulation of BA composition. Methods: We used high-fat diet (HFD)-fed foz/foz and high-fructose western diet-fed C57BL/6J mice, and compared them to their respective controls. Mice received a diet supplemented with deoxycholic acid (DCA) to modulate BA composition. Results: Compared to controls, mice with NASH had lower concentrations of BAs in their portal blood and bile, while systemic BA concentrations were not significantly altered. Notably, the concentrations of secondary BAs, and especially of DCA, and the ratio of secondary to primary BAs were strikingly lower in bile and portal blood of mice with NASH. Hence, portal blood was poor in FXR and TGR5 ligands, and conferred poor anti-inflammatory protection in mice with NASH. Enhanced primary BAs synthesis and conversion of secondary to primary BAs in NASH livers contributed to the depletion in secondary BAs. Dietary DCA supplementation in HFD-fed foz/foz mice restored the BA concentrations in portal blood, increased TGR5 and FXR signaling, improved the dysmetabolic status, protected from steatosis and hepatocellular ballooning, and reduced macrophage infiltration. Conclusions: BA composition in the enterohepatic cycle, but not in systemic circulation, is profoundly altered in preclinical models of NASH, with specific depletion in secondary BAs. Dietary correction of the BA profile protected from NASH, supporting a role for enterohepatic BAs in the pathogenesis of NASH. Lay summary: This study clearly demonstrates that the alterations of enterohepatic bile acids significantly contribute to the development of non-alcoholic steatohepatitis in relevant preclinical models. Indeed, experimental modulation of bile acid composition restored perturbed FXR and TGR5 signaling and prevented non-alcoholic steatohepatitis and associated metabolic disorders.
format article
author Justine Gillard
Laure-Alix Clerbaux
Maxime Nachit
Christine Sempoux
Bart Staels
Laure B. Bindels
Anne Tailleux
Isabelle A. Leclercq
author_facet Justine Gillard
Laure-Alix Clerbaux
Maxime Nachit
Christine Sempoux
Bart Staels
Laure B. Bindels
Anne Tailleux
Isabelle A. Leclercq
author_sort Justine Gillard
title Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
title_short Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
title_full Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
title_fullStr Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
title_full_unstemmed Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
title_sort bile acids contribute to the development of non-alcoholic steatohepatitis in mice
publisher Elsevier
publishDate 2022
url https://doaj.org/article/d288e103d667458db40d774aae2af880
work_keys_str_mv AT justinegillard bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT laurealixclerbaux bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT maximenachit bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT christinesempoux bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT bartstaels bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT laurebbindels bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT annetailleux bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
AT isabellealeclercq bileacidscontributetothedevelopmentofnonalcoholicsteatohepatitisinmice
_version_ 1718425004763250688